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Abstract: The impact of meat protein on metabolic regulation is still disputed, and may 1 
be influenced by protein level. This study aimed to explore the effects of casein, pork 2 
and chicken proteins at different protein levels (40% E vs. 20% E) on body weight 3 
regulation, body fat accumulation, serum hormone levels, and inflammatory 4 
factors/metabolites in rats maintained on high-fat (45% E fat) diets for 84 d. Increased 5 
protein-levels resulted in a significant reduction in body fat mass and an increase in 6 
serum levels of the anti-inflammatory cytokine IL-10, independent of protein source. 7 
Analysis of blood via untargeted metabolomics analysis identified 8, 4 and 4 8 
metabolites significantly altered by protein level, protein source, and a protein 9 
level*source interaction, respectively. Together, the effects of casein, chicken and pork 10 
protein on the regulation of body fat accumulation and blood metabolite profile are 11 
largely dependent on protein level, and less attributable to the protein source. 12 
 13 






With the globally increasing prevalence of obesity and metabolic syndrome, 16 
dietary protein is regarded as the most promising macronutrient for improving body 17 
composition and metabolic profile1. Meat protein is an important animal-derived 18 
dietary protein consumed by humans. In 2015, the World Health Organization (WHO) 19 
classified red and processed meat as “probably carcinogenic to humans” and 20 
“carcinogenic to humans”, respectively2, adding to a resurgence of interest in 21 
understanding the biological functions of meat proteins and their relationships to human 22 
health3-8.  23 
To date, studies exploring the biological effects of meat proteins have been 24 
conducted by several research groups, including groups from China3-8, Japan (mainly 25 
on fish protein)9, Norway and Denmark10-11. These studies have mainly focused on the 26 
impact of meat proteins on energy regulation, glucose or lipid metabolism3, 6-7, 9-11, and 27 
gut microbiota6, 8, 12. Previously, we investigated the effect of different protein sources 28 
(casein, soy, beef, pork, chicken and fish) at recommended normal protein levels (20% 29 
E) on growth and metabolism in healthy young rats3-5, 7. Short-term (7 or 14 days) 30 
feeding of the different protein sources resulted in distinct physiological, transcriptome 31 
and proteome changes. Both red (beef and pork) and white (chicken and fish) meat 32 
proteins displayed beneficial effects on growth and lipid metabolism when compared 33 
to their casein and soy protein counterparts7. Conversely, intake of high-fat diet in 34 
combination with normal level (about 18-20% E) beef protein for 12 weeks increased 35 
dyslipidemia, hypercholesterolemia, and triglycerides accumulation in liver and led to 36 
systemic inflammation, impaired glucose metabolism and insulin resistance, when 37 
compared to casein and soy protein6. Thus, highlighting the discrepancies between 38 





dietary fat and protein levels.  40 
It has been reported that in rats, increasing dietary protein levels reduces lipid 41 
accumulation in the adipose tissue, attenuating the metabolic dysfunction associated 42 
with high-fat or -sucrose induced obesity13-14. However, most of these studies have been 43 
focused primarily on dairy proteins, like casein and whey13. The implications of high 44 
level meat protein intake on metabolic health remains distinctively lacking. 45 
Epidemiologic studies link high consumption of red or processed meat with increased 46 
risk of obesity and diabetes15-16, however such epidemiologic results still lack validation 47 
from rigorous animal studies. Here, we provide high-fat diet maintained rats with one 48 
of three protein sources (casein, pork or chicken) at either high (40% E) or normal (20% 49 
E) protein levels, in order to clarify the effects of high level meat protein consumption 50 
on body composition and metabolic health. To achieve this, we monitored body weight/ 51 
body fat mass, and measured blood hormone/inflammatory factors as well as employing 52 
a metabolomics approach. 53 
Materials & Methods 54 
Protein Sources and Diets 55 
Detailed methods for preparation of chicken and pork protein sources have been 56 
previously described3. Briefly, cooked meat was freeze-dried and broken into powder. 57 
Dry meat powder was defatted with methylene chloride/methanol (2: 1, v: v). The final 58 
meat protein powders consisted of more than 90% of protein. 59 
Seven diets were prepared based on 3 main formulas of D12450H, D12451 and 60 
D12451m (Supplementary table 1). Low fat diet with casein was prepared according 61 
to formula of Research Diet D12450H (10% E fat, 20% E protein, 70% E carbohydrate) 62 
and was used as low-fat control diet (LF group). High fat (HF) diet with casein was 63 





carbohydrate) and used as high-fat control diet (CS group). Other two HF diets with 65 
chicken (CK group) or pork (PK group) protein sources were prepared according to the 66 
same diet formula of CS diet (D12451) in which the protein source (casein) was fully 67 
replaced by isolated proteins from pork or chicken. High-fat-high-protein (HFHP) diet 68 
with casein (HCS group) was prepared by increasing protein but reducing carbohydrate 69 
(only starch) in D12451 (45% E fat, 40% E protein, 15% E carbohydrate, D12451m). 70 
Other two HFHP diets with chicken (HCK group) or pork (HPK group) protein sources 71 
were prepared according to the same diet formula of HCS diet (D12451m) in which the 72 
casein was fully replaced by isolated proteins from pork or chicken.  73 
Animals and Sample Collection 74 
All animals were handled in accordance with the guidelines of the Ethical 75 
Committee of Experimental Animal Center of China Pharmaceutical University (the 76 
license number is SYXK (Su) 2018-0019). The Wistar rat employed in this experiment 77 
is considered the standard rodent for diet-induced obesity experiment due to their 78 
susceptibility to diet induced obesity and insulin resistance17. After a one-week adaption 79 
period, 49 male Wistar rats with initial body weight of 180-200g were randomly 80 
assigned into the 7 groups (n=7 rats in each group). To test long-term effects of dietary 81 
proteins on regulation of body weight and metabolic health, rats were fed for 12 weeks 82 
diets of LF, CS, CK, PK, HCS, HCK or HPK, respectively. Feed intakes and body 83 
weight was measured every 3 days. On day 84, rats were deprived of feed but were 84 
given free access to water for 6 hours prior to sacrifice. Immediately following 85 
euthanasia, blood was taken and serum was isolated. Perirenal and epididymis fat pad 86 
were obtained and weighed. All samples were snap frozen in liquid nitrogen and stored 87 
at -80 °C until analysis.  88 





OGTT was conducted on day 80. Rats were submitted to a 6-h fasting prior to 90 
glucose administration. Each rat was given 2g glucose /kg body weight by gavage. Tail 91 
vein blood drops were collected for glycemia measurement before (0 min) and after 92 
glucose gavage (30min, 60min, 90min and 120min) through a glucometer (Jiangsu 93 
Yuyue Medical Equipment & Supply Co. Ltd., Shanghai, China). The value of area 94 
under curve (AUC) was calculated.  95 
Blood Hormone and Inflammatory Factors Detection 96 
Serum insulin concentrations were detected using ELISA kits (Elabscience 97 
Biotechnology Co., Ltd., Wuhan, Hubei, China) according to the manufacturer’s 98 
instructions. Serum leptin concentration were detected using Bio-Plex Pro Rat Diabetes 99 
Leptin kits (Bio-Rad Laboratories, Inc., Hercules, California, USA) according to the 100 
manufacturer’s instructions. Concentrations of serum inflammation factors of tumor 101 
necrosis factor-α (TNF‑α), monocyte chemoattractant protein-1(MCP1), interleukin-6 102 
(IL‑6) and interleukin-10 (IL10) were detected using Bio-Plex Cytokine Express 5-Plex 103 
(Bio-Rad Laboratories, Inc., Hercules, California, USA) according to the 104 
manufacturer’s instructions.  105 
Blood Untargeted Metabolomics Detection 106 
Metabolites Extraction. All serum samples were pooled as QC (quality control) 107 
sample. Serum (n=7 in each group) were extracted with methanol, with L-2-108 
Chlorophenylalanine (1mg/mL stock in dH2O) as internal standard. After centrifuging 109 
for 15min at 12000rpm at 4℃, the supernatant was taken and dried completely in a 110 
vacuum concentrator without heating. Methoxy amination hydrochloride (20mg/mL in 111 
pyridine) was added to the dried sample, and the solution was incubated at 80℃ for 112 
30min. Then, BSTFA regent (1% TMCS, v/v) was added to the sample aliquots, and it 113 





when cooling to the room temperature.  115 
GC-TOF-MS Analysis. All samples were analyzed using Agilent 7890 gas 116 
chromatograph system coupled with a Pegasus HT time-of-flight mass spectrometer 117 
(GC-TOF-MS). The system utilized a DB-5MS capillary column coated with 5% 118 
diphenyl cross-linked with 95% dimethylpolysiloxane (30m×250μm inner diameter, 119 
0.25μm film thickness; J&W Scientific, Folsom, CA, USA). A 1μL aliquot of the 120 
analyte was injected in splitless mode. Helium was used as the carrier gas, the front 121 
inlet purge flow was 3mL/min, and the gas flow rate through the column was 1mL/min. 122 
The initial temperature was kept at 50°C for 1min, then raised to 310°C at a rate of 123 
20°C/min, then kept for 6min at 310°C. The injection, transfer line, and ion source 124 
temperatures were 280, 280, and 250°C, respectively. The energy was -70eV in electron 125 
impact mode. The mass spectrometry data were acquired in full-scan mode with the 126 
m/z range of 50-500 at a rate of 20 spectra per second after a solvent delay of 4.7min.  127 
Data Preprocessing and Annotation. MS-DIAL software and FiehnBinbase 128 
database18 were used for raw peaks exacting, the data baselines filtering and calibration 129 
of the baseline, peak alignment, deconvolution analysis, peak identification and 130 
integration of the peak area19. Both of mass spectrum match and retention index match 131 
were considered in metabolites identification. Remove peaks detected in ≤50% of QC 132 
samples, or <50% samples of every group (except QC group), or RSD＞30% in QC 133 
samples. Blood metabolomics data was analyzed by using the web tool of 134 
MetaboAnalyst 4.0 (https://www.metaboanalyst.ca/)20. Before comparison, 135 
metabolomics data was normalized by log-transforming and auto-scaling (i.e. mean-136 
centered and divided by the standard deviation of each variable). KEGG pathway over 137 
representation analysis of significant metabolomics items were performed by using 138 





The overlaps of significant metabolomics items of different comparisons are shown in 140 
Venn plots drawn by using a web tool on https://bioinfogp.cnb.csic.es/tools/venny/ 141 
index. html. All significant features were shown in a clustered heatmap, where 142 
clustering was based on the Euclidean distance calculated using Ward algorithm. 143 
Correlations of significant features were analyzed using Pearson method. 144 
Statistical Analysis 145 
Statistical analysis was performed using SPSS for Windows 16.0 software (SPSS 146 
Inc., Chicago, Illinois, USA). For comparisons of effects of low fat (LF), high fat (HF) 147 
and high fat high protein (HFHP) diets, the LF group was set as control. CS, CK and 148 
PK groups were combined as a HF super-group. HCS, HCK and HPK groups were 149 
combined as a HFHP super-group. The effects of LF, HF and HFHP diets were tested 150 
by using one-way ANOVA and Duncan post hoc test. Without LF group, the other 6 151 
groups (CS, CK, PK, HCS, HCK and HPK) were tested by using two-factor ANOVA 152 
with dietary protein source and level as fixed factors. P < 0·05 was considered 153 
significant. When the main effects of protein source were significant, multiple 154 
comparisons of HF groups (CS, CK and PK) and HFHP (HCS, HCK and HPK) groups 155 
were done by using Duncan post hoc method. When the interaction effects of protein 156 
level and source were significant, multiple comparisons of the 6 groups (CS, CK, PK, 157 
HCS, HCK and HPK groups) were done by using Duncan post hoc method.   158 
Results 159 
Growth Performance and Body Fat Mass 160 
The initial body weight (IBW) of rats was constant across all 7 groups (Figure 1 161 
A). The final body weight (FBW), body weight gain (BWG) and daily body weight 162 
gain (DBWG) of rats fed HF diets was significantly higher (by 18.5%) than that of rats 163 





with that of HF- and LF-fed rats, but was not significantly different from either (P > 165 
0.05). The daily feed intake (DFI) of rats in the 7 groups did not differ. However, the 166 
daily energy intake (DEI) of rats fed HF and HFHP diets was significantly higher (by 167 
21%) than that of rats fed LF diet. Changes in white adipose tissue mass of LF, HF and 168 
HFHP groups were similar to changes observed in BWG and DBWG (Figure 1 B). 169 
Perirenal (PATW), epididymal (EATW) and total (WATW = PATW + EATW) white 170 
adipose tissue weights of rats fed HF diets were significantly higher (by 31.5%) than 171 
that of rats fed LF diet, as to the relative percent content of perirenal (PATW/FBW), 172 
epididymal (EATW/FBW) and total (WATW/FBW) white adipose tissue to the final 173 
body weight. It is worth noting that the EATW of rats fed HFHP diets was significantly 174 
lower (by 15.2%) than that of rats fed HF diets (P < 0.05). 175 
In order to test the effects of dietary protein source and level on growth and body 176 
fat mass of rats, six groups of CS, CK, PK, HCS, HCK and HPK (without LF) were 177 
compared using two-factor ANOVA (Figure 1). Increasing dietary protein levels (from 178 
20% E to 40% E) significantly reduced EATW (protein level: F value = 6.476, P = 179 
0.015) and EATW/FBW (protein level: F value = 5.552, P = 0.024) of rats fed HF diets 180 
whilst protein source had no effects on body weight or fat mass of rats. 181 
Oral Glucose Tolerant Test (OGTT) and Serum Hormones 182 
OGTT test was conducted on day 80 to measure the blood glucose clearance ability 183 
of rats fed different protein diets (Figure 2 A). Compared to the LF group, rats in HF 184 
and HFHP groups had significantly higher blood glucose levels 30 min after glucose 185 
gavage (glucose-30 min) and a significantly higher area under curve value (glucose-186 
AUC, by 12% and 15% respectively). Two-factor ANOVA analysis showed significant 187 
effects of protein level on glucose-0 min (F value = 5.358, P = 0.026) and -60min (F 188 





to higher glucose-60 min (by 11%) than HF group (P < 0.05). Protein source had no 190 
significant effects on glucose tolerance of rats. Similarly, no significant changes were 191 
found for serum insulin and leptin between groups (Figure 2 B). 192 
Serum Inflammatory Factors 193 
Several serum inflammatory factors including TNF-α, MCP-1, IL-6 and IL-10 194 
were measured (Figure 2 B). Compared with LF diet, concentrations of TNF-α and IL-195 
10 were increased significantly by HFHP diets (P < 0.05, by 94.7% and 118% 196 
respectively), and concentrations of MCP-1 were increased significantly by HF diet (P 197 
< 0.05, by 47.1%). For effects of protein source and level on blood inflammatory factors, 198 
there were no significant effects of protein source on blood inflammatory factors. 199 
However, the effects of protein level on IL-10 concentrations were significant (F value 200 
= 4.498, P = 0.042). Compared to 20% E protein diet (HF group), 40% E protein diet 201 
(HFHP group) increased IL-10 concentrations significantly (by 68.2%).  202 
Blood Untargeted Metabolome 203 
A total of 112 non-redundant metabolites were detected in the serum of the rats. 204 
Fifteen metabolites were found significantly changed across LF, HF and HFHP groups 205 
(P < 0.05). Two-factor ANOVA analysis revealed that 4 and 8 metabolites were 206 
significantly altered by protein source and protein level respectively, a further 4 207 
metabolite changes were associated with a protein-source*protein-level interaction. 208 
When presented in a Venn plot (Figure 3), 24 unique metabolites with significant 209 
changes were identified. Eight metabolites were specific for the comparison of LF, HF, 210 
and HFHP groups, with both protein and non-protein related effects. Metabolites 2-211 
hydroxybutyric acid and palmitoleic acid were relatively high in LF group compared to 212 
the HF and HFHP groups, and thus are likely regulated by lipid levels which 213 





levels were influenced by protein source. and were increased in casein groups (CS and 215 
HCS) when compared to other meat protein groups (CK, PK, HCK and HPK) (Figure 216 
3). Both lipid level and protein source were found to regulate myristic acid. L-tyrosine, 217 
L-histidine, 5-aminopentanoic acid, N-acetylornithine and L-glutamine were regulated 218 
by effects of protein level alone, and were particularly decreased in HF groups. In 219 
contrast, xanthosine, D-fructose and turanose were increased in HF groups when 220 
compared to HFHP. Thus, highlighting the importance of the protein: carbohydrate ratio 221 
in regulating metabolite profile. 222 
Utilizing a heatmap cluster analysis incorporating the 24 unique blood metabolites 223 
together with the significantly altered parameters of body weight, body fat mass and 224 
blood inflammatory factors (Figure 4). Three distinct clusters were observed, including 225 
a HF cluster of CK, PK and CS, a HFHP cluster of HCK, HPK and HCS, and a LF 226 
cluster. 227 
Correlations of significant features were shown in Figure 5. See Pearson correlate 228 
coefficient and P value in Supplementary table 2 & 3. DEI positively correlated with 229 
body weight gain (FBW, BWG and DBWG) and body fat mass (Pearson correlate 230 
coefficient > 0.4 & P < 0.01). The serum metabolites myristic acid, 2-hydroxybutyric 231 
acid and palmitoleic acid negatively correlated with DEI, body weight and body fat 232 
mass (Pearson correlate coefficient < -0.28 & P < 0.05). Additionally, the serum 233 
metabolites 5-aminopentanoic acid, L-tyrosine, N-acetylornithine, L-glutamine and L-234 
proline negatively correlated with body weight and body fat mass (Pearson correlate 235 
coefficient < -0.3 & P < 0.05). Serum IL-10 and TNF-α negatively correlated with 236 
serum palmitoleic acid (Pearson correlate coefficient < -0.3 & P < 0.05).  237 
Pathway analysis (Table 1) showed that L-glutamine, N-acetylornithine, creatine, 238 





histidine, L-tyrosine and L-proline were involved in aminoacyl-tRNA biosynthesis. 240 
These pathways were regulated by both protein level and protein source. Pathways of 241 
glyoxylate and dicarboxylate metabolism were regulated by both protein source and fat 242 
level. Pathways of nitrogen metabolism and beta-Alanine metabolism was regulated by 243 
protein level only.  244 
Discussion 245 
In this study we evaluate the effects of protein source (casein, pork and chicken) 246 
and protein level (normal and high) on body fat accumulation and metabolic function 247 
of healthy rats maintained on a high-fat diet. As expected, HF diet induced body weight 248 
gain, increasing 18.5% (P < 0.05), compared to the LF diet. A subsequent 31.5% 249 
increase (P < 0.05) in white adipose tissue weight was identified in HF maintained rats, 250 
indicating that body fat was more sensitive measure for assessing high-fat induced 251 
obesity in animals than body weight, as described by Woods et al. (2003)21. The body 252 
weight gain of HF maintained rats relates to the higher energy intake from the HF diets 253 
(21% higher), and further supported by correlation analysis showing a positive 254 
correlation between DEI, body weight and fat mass (Pearson correlate coefficient > 0.4 255 
& P < 0.01). When increasing protein levels in the HF diets compensated by reducing 256 
carbohydrate (starch) levels (i.e. HFHP diets), the EATW and EATW/BW of rats 257 
provided with HFHP was decreased 15.2% (P < 0.05) and 11.0% (P < 0.05), 258 
respectively. However, DFI, DEI and body weight gain of HFHP rats (although 259 
nominally reduced by 8.8%) was not significantly different from the HF groups (P > 260 
0.05), suggesting that increased dietary protein content may reduce high-fat induced 261 
body fat accumulation without reducing energy intake and body weight gain. This was 262 
similarly observed by Chaumontet et al. (2015), who purported that high protein diets 263 





study, the body fat reducing effects of high protein diets appeared to be independent of 265 
protein sources. Therefore, chicken, pork and casein were equally effective at reducing 266 
body fat mass associated with HF diet.  267 
Insulin resistance accompanies increased body fat accumulation associated with 268 
high-fat induced obesity21. The oral glucose tolerance test (OGTT) is often employed 269 
to evaluate insulin resistance22. Compared to the LF diet, HF and HFHP diets reduced 270 
glucose tolerance (i.e. increased glucose-AUC) of rats independent of differences in 271 
protein level and source. However, the serum insulin concentrations did not differ 272 
between groups (P > 0.05). These findings were not in agreement with our previous 273 
study7, which suggests that red meat may increase risk of insulin resistance in rats. 274 
However, Myrmel et al11 also found that intake of pork protein based HFHP diet 275 
reduced glucose tolerance and insulin sensitivity of rats, compared to casein based 276 
HFHP diets. Chicken protein was not compared in their study. Previously, we have also 277 
identified that a cluster of gene sets involved in the insulin signaling pathway was 278 
mostly inhibited by chicken protein when compared to casein and other meat proteins4. 279 
The heterogeneity of these findings highlights the need for further studies to verify the 280 
effects of meat proteins on insulin resistance.  281 
Obesity is closely associated with a state of ‘low-grade’ chronic inflammation, 282 
shown by increased levels of inflammatory markers23. Obese people and animals often 283 
show a higher level of serum pro-inflammatory cytokines, such as TNF‑α and IL‑624. 284 
In this study, compared to the LF diet, both HF and HFHP diets increased serum 285 
concentrations of TNF‑α (by 57.9% and 94.7%), IL-6 (by 18.2% and 47.7%) and MCP-286 
1 (by 47.1% and 13.9%) of rats. However, these pro-inflammatory cytokines were not 287 
different between HF and HFHP groups (P > 0.05). Therefore, these increased pro-288 





However, compared to the HF diet, the HFHP diet resulted in a significant increase of 290 
serum anti-inflammatory cytokine IL-10 (by 68.2%, P < 0.05). These increased anti-291 
inflammatory cytokine IL-10 was supposed to be stimulated by the effects of higher 292 
protein level in HFHP diet than in HF diet. Previous studies have shown a protective 293 
role of IL-10 in regulation of metabolic inflammation and insulin sensitivity25. In 294 
addition, Clement et al. (2004) found that IL-10 expression was increased following 295 
weight loss in obese patients26, as observed to some extent in this study, with HFHP fed 296 
rats displaying increased serum IL-10 following body fat mass loss. Interestingly, 297 
protein source had no effect on serum IL-10, and thus a high protein intake in general 298 
could be beneficial for protecting high-fat induced metabolic inflammation. 299 
Obesity-related chronic inflammation is principally triggered by nutrients and 300 
metabolic surplus and therefore has close interface with metabolic responses27. Blood 301 
metabolite profiles shifted significantly in response to the protein diets, with protein 302 
level (8 metabolites) resulting in greater effects on the regulation of blood metabolome 303 
than protein source (4 metabolites). Moreover, protein source*level interaction was also 304 
evident.  305 
At the individual metabolites level, HF and HFHP resulted in lower palmitoleic 306 
acid and 2-hydroxybutyrate compared to LF fed rats, suggesting that lipid mobilization 307 
and fatty acid oxidation was reduced by HF and HFHP diets. Palmitoleic acid 308 
(palmitoleate) is a monounsaturated fatty acid most abundant in serum, adipose tissue 309 
and liver28. Endogenous palmitoleic acid mainly originates from de novo lipogenesis in 310 
the adipose tissue and liver28. Increased circulating concentrations of free palmitoleic 311 
acid in the blood suggests increased lipid mobilization from adipose tissue. Therefore, 312 
palmitoleic acid was referred to as a “lipokine” and has been associated with increased 313 





PPAR-α is a transcription factor which plays a central role in controlling the fatty acid 315 
β-oxidation30. It has been shown that increased fatty acid oxidation contributes to 316 
elevated 2-hydroxybutyrate31. In contrast, the reduced serum palmitoleic acid and 2-317 
hydroxybutyrate in HF and HFHP groups reflected a suppressed lipid mobilization and 318 
fatty acid oxidation, compared to the LF fed rats. The reduced lipid catabolism in HF 319 
fed rats is likely associated with the increased body weight and fat mass observed. This 320 
is supported by the correlation analysis, showing a negative correlation of blood 321 
palmitoleic acid and 2-hydroxybutyric acid with body weight and fat mass. At the same 322 
time, blood palmitoleic acid negatively correlated with glucose-AUC and blood TNF-323 
a, suggesting that palmitoleic acid is associated with decreased insulin resistance and 324 
expression of proinflammatory markers, and is consistent with Frigolet et al. (2017)28. 325 
Notably, serum creatine, L-proline and ketoleucine were different between casein 326 
and meat proteins. Creatine is a nitrogenous organic compound found in muscle and is 327 
available in the diet through consumption of meat32. Therefore, the higher serum 328 
creatine in rats fed meat proteins was expected. Creatine is a tripeptide compound 329 
composed of arginine, methionine and glycine, and thus is involved in metabolism of 330 
these amino acids32. Ketoleucine is an intermediate product of leucine metabolism33. In 331 
this study, blood L-proline and ketoleucine were relatively high in casein groups, but 332 
low in chicken and pork protein groups. These differences may be partly related to the 333 
amino acid compositions of different dietary proteins. It has been shown that casein has 334 
higher contents of proline and leucine than chicken and pork proteins10. Based on this, 335 
pathway analysis showed that arginine and proline metabolism were the main metabolic 336 
processes regulated differently by casein and meat proteins. In addition, serum L-337 





proline and its metabolism might contribute largely to the differences of anti-obesity 339 
effects of casein and meat proteins.  340 
On the other hand, serum L-histidine, 5-aminopentanoic acid, L-tyrosine, N-341 
acetylornithine and L-glutamine were mainly different between high and low protein 342 
diets. They were relatively high in HFHP fed rats but low in HF fed rats. Pathway 343 
analysis showed that nitrogen metabolism and aminoacyl-tRNA biosynthesis were the 344 
main metabolic processes regulated differently by protein levels in diets. In addition, 345 
blood metabolites 5-aminopentanoic acid, L-tyrosine, N-acetylornithine and L-346 
glutamine were negatively correlated with body weight and body fat mass. Therefore, 347 
compared to low protein diets, the anti-obesity effects of high protein diets could mainly 348 
attribute to the increased blood L-histidine, L-tyrosine and L-glutamine and their 349 
related nitrogen metabolism. These ATP-consuming metabolic processes could be 350 
associated with the augmented energy expenditure in rats fed high protein diet.  351 
Taken together, the effects of dietary proteins on body fat accumulation and 352 
metabolic health were dependent largely on protein level, but less on protein source. 353 
Intake of high content of chicken and pork proteins had similar effects with casein on 354 
reducing body fat mass of rats fed HF diets. These anti-obesity effects of dietary 355 
proteins were closely related to the changes of blood metabolome. The effects of protein 356 
levels were mainly related to changes of blood L-histidine, L-tyrosine, L-glutamine, 5-357 
aminopentanoic acid and N-acetylornithine. While, the effects of protein sources were 358 
mainly related to changes of blood L-proline, ketoleucine, creatine and citric acid. 359 
Further studies are still needed to expound the molecular mechanism behind the diverse 360 
metabolic regulation effects of different protein sources and levels. 361 





AUC: area under curve; BWG: the body weight gain of rats from day 0 to day 84; 363 
CK: high fat 20% E chicken protein group; CS: high fat 20% E casein group; DBWG: 364 
the daily body weight gain of rat during 84-day feeding; DEI: the daily energy intake 365 
of rats during 84-day feeding; DFI: the daily feed intake of rats during 84-day feeding; 366 
EATW: epididymal adipose tissue weight; EATW/FBW: relative percent content of 367 
epididymal adipose tissue to the final body weight of rats; FBW: the final body weight 368 
of rats on day 84; HCK: high fat 40% E chicken protein group; HCS: high fat 40% E 369 
casein group; HF: high fat; HFHP: high fat high protein; HPK: high fat 40% E pork 370 
protein group; IBW: the initial body weight of rats on day 0; IL-6: interleukin 6; IL-10: 371 
interleukin 10; LF: low fat; MCP-1: monocyte chemoattractant protein-1; OGTT: oral 372 
glucose tolerant test; PATW: perirenal adipose tissue weight; PATW/FBW: relative 373 
percent content of perirenal adipose tissue to the final body weight of rats; PK: high fat 374 
20% E pork protein group; TNF-α: tumor necrosis factor α; WATW: total white adipose 375 
tissue weights (WATW = PATW + EATW); WATW/FBW: relative percent content of 376 
total white adipose tissue to the final body weight of rats.  377 
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Figure 1 (A) the body weight, feed intake and (B) body fat mass of rats fed different 
diets.  
Note: IBW: the initial body weight of rats on day 0; FBW: the final body weight of rats 
on day 84; BWG: the body weight gain of rats from day 0 to day 84; DBWG: the daily 
body weight gain of rat during 84-day feeding; DFI: the daily feed intake of rats during 
84-day feeding; DEI: the daily energy intake of rats during 84-day feeding; PATW: 
perirenal adipose tissue weight; EATW: epididymal adipose tissue weight; WATW: 
total white adipose tissue weights (WATW = PATW + EATW); PATW/FBW: relative 
percent content of perirenal adipose tissue to the final body weight of rats; EATW/FBW: 
relative percent content of epididymal adipose tissue to the final body weight of rats; 
WATW/FBW: relative percent content of total white adipose tissue to the final body 
weight of rats. LF: low fat group; HF: high fat super group = CS + CK + PK; HFHP: 
high fat high protein super group = HCS + HCK + HPK; CS: high fat 20% E casein 
group; CK: high fat 20% E chicken protein group; PK: high fat 20% E pork protein 
group; HCS: high fat 40% E casein group; HCK: high fat 40% E chicken protein group; 
HPK: high fat 40% E pork protein group; Results are mean ± SD. The number of 
replications of LF, HF and HFHP groups were 7, 21 and 21, respectively. The number 
of replications of CS, CK, PK, HCS, HCK and HPK groups were 7. Different letters 
above bars mean significant different (P < 0.05) tested by one-way ANOVA and Duncan 
post hoc analysis. NS: no significant effects of protein source or protein level by two-
factor ANOVA (P > 0.05). L: significant effect of protein level (L) by two-factor 






Figure 2 (A) Oral glucose tolerant test results, and (B) serum hormones and 
inflammatory factors of rats fed different diets.  
Note: LF: low fat group; HF: high fat super group = CS + CK + PK; HFHP: high fat 
high protein super group = HCS + HCK + HPK; CS: high fat 20% E casein group; CK: 
high fat 20% E chicken protein group; PK: high fat 20% E pork protein group; HCS: 
high fat 40% E casein group; HCK: high fat 40% E chicken protein group; HPK: high 
fat 40% E pork protein group; TNF-α: tumor necrosis factor α; IL-6: interleukin 6; 
MCP-1: monocyte chemoattractant protein-1; IL-10: interleukin 10. Results are mean 
± SD. The number of replications of LF, HF and HFHP groups were 7, 21 and 21, 
respectively. The number of replications of CS, CK, PK, HCS, HCK and HPK groups 
were 7. Different letters above bars mean significant differences (P < 0.05) tested by 
one-way ANOVA and Duncan post hoc analysis. NS: no significant effects of protein 
source or protein level tested by two-factor ANOVA (P > 0.05). L: significant effect of 
protein level (L) tested by two-factor ANOVA (P < 0.05).  
 
Figure 3 Venn plot of serum metabolites with significant differences. 
Note: LF_HF_HFHP: comparison of LF, HF and HFHP groups; prot_source: effects of 
protein source tested by two-factor ANOVA; prot_level: effects of protein level tested 
by two-factor ANOVA; interaction: interaction effects of protein source and level tested 
by two-factor ANOVA; Different letters in each row of heatmaps mean significant 
differences (P < 0.05) tested by Duncan post hoc analysis  
 
Figure 4 Clustered heatmap of regulations of significant features.  
Note: E: color of effects. Pink means effects of protein source. Green means effects of 





protein level and protein source. Blue means effects of fat level. Black means none-
blood metabolomics items. 
 
Figure 5 Clustered heatmap of correlations of significant features.  
Note: E: color of effects. Pink means effects of protein source. Green means effects of 
protein level, i.e. ratio of protein to carbohydrate. Yellow means interaction effects of 
protein level and protein source. Blue means effects of fat level. Black means none-






Table 1. Pathway analysis of 24 blood metabolites with significant changes 
Pathways Hits P value Effects 
Arginine and proline metabolism L-glutamine, N-acetylornithine, 
creatine, spermine, L-proline 
0.0016 PL, PS 
Aminoacyl-tRNA biosynthesis L-glutamine, L-histidine, 
L-tyrosine, L-proline 
0.0060 PL, PS 
Glyoxylate and dicarboxylate 
metabolism 
citric acid, glyceric acid, L-
glutamine  
0.013 PS, FL  
Nitrogen metabolism L-glutamine, L-histidine 0.014 PL 
Pentose phosphate pathway glyceric acid, gluconolactone  0.042 FL 
beta-Alanine metabolism  spermine, L-histidine 0.042 PL 
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